Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
5s are gone. Only 305,000 @ 6.
m2m
I think a purchase at .005 represents excellent risk/reward.
m2m
YW. The listing is based on the % grade of the deposit not the size. SRSR has one of the largest in size and apparently it's pretty easy to get out of the ground.
m2m
Rockstone Research has some good stuff on niobium:
Trump Metal http://rockstone-research.com/index.php/en/research-reports/2311-Drill-Program-to-Find-One-of-the-Trump-Metals:-Niobium
List of known deposits http://rockstone-research.com/index.php/en/news/1130-Niobium-in-a-nutshell SRSR is #20 on list
m2m
I'm not guessing.
m2m
It's funny NOW!
m2m
Hi georgie,
I found you on Rig's board and am following you.
I see you often refer to upper bollie breakouts. Check out the recent one on SRSR. Accumulation looks good also.
m2m
I know. That's why I said "(for now)"
m2m
Here's a good site for charts:
https://www.tradingview.com/chart/?symbol=OTC:SRSR
There's a ton of indicators (tab at top)
m2m
SRSR is #10 on Breakout Boards (for now).
https://investorshub.advfn.com/boards/breakoutboards.aspx
m2m
Yep!
m2m
Or Wednesday or Thursday or some day next week or someday
thereafter.
Ha!
m2m
That's one crummy chart. However, I am glad to welcome and see you back.
m2m
or maybe I've been staring at L2 for too long.
haha
m2m
Doesn't feel like a leak unless "whatever it is" needs a few days to unwind. It does have a good feel to it whatever it is.
(knock on wood)
m2m
Yep. Level 2 looking decent.
Just need a spark to ignite lift off.
m2m
ViaDerma, Inc. Commences First Manufacturing Run and will Meet the 2nd Quarter Product Distribution Milestone
Published: June 12, 2017 10:18 a.m. ET
Jun 12, 2017 (Marketwired via COMTEX) -- LOS ANGELES, CA--(Marketwired - June 12, 2017) - ViaDerma, Inc. (otc pink:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has commenced manufacturing of its FDA registered topical antibiotic. ViaDerma, Inc. has completed the quality control and approved labeling for the product and will begin distribution of the wound care drug in June. The "Quality Control" plan has been executed and now meets the strict guidelines starting with the manufacturer all the way through to the point of purchase. To assure a solid growth strategy, the Company's go to market expert and strategist, Ivan Klarich, has just returned from multi country Asian tour for ViaDerma where the product was well received. The Company is expecting several countries to order 10,000 units to begin the product launch in several Asian countries. The Company plans to continue to add additional products and offer those new products directly to the same distributors. The Company plans to announce additional new products for its proprietary specialty pharmaceutical product line in the very near future.
The Company's President, Dr. Christopher Otiko, said, "We are all pleased to have a product in manufacturing and to meet our goals. Our product manufacturer will be able to manufacture most of our products and we look forward to building a lasting relationship to deliver high quality pharmaceuticals to our distributors. Since my presentation at DFCON or the Diabetic Foot Global Conference in Houston, TX, in March, we have had a tremendous amount of interest in our topical antibiotic. Our goal is to have our product added to all diabetic foot ulcer treatment protocols around the globe."
About ViaDerma, Inc. ViaDerma, Inc. (otc pink:VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's lead product, a tetracycline-based topical antibiotic, uses an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD's and THC with the delivery system was filed in 2017. The use of CBD's is for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com
If it's good news, "Long shareholders who are deep in the RED" won't be selling and this should run to multi pennies in a hurry.
m2m
Someone must have seen Currah and Keevil at Costco shopping for adult diapers.
m2m
Down 65% from the high on the 4/25 pump PR. Sad really but that's what you get from these guys.
m2m
Hmmm. Some bidders are stepping up.
m2m
Here's another based on a spin-out that never happened:
http://www.siliconinvestor.com/readmsg.aspx?msgid=28327453
m2m
Here's a SRSR estimated valuation from five years ago:
http://www.siliconinvestor.com/readmsg.aspx?msgid=28327472
m2m
Dar she bows! Down 20%. More 2 come IMO. Investors are on to the Currah/Keevil fiasco.
m2m
Can't argue with you there! LOL!
m2m
Yep. After the block at .0034, looks very thin.
m2m
Share Info at OTC Markets now reads:
Share Structure
Market Value1 Not Available
Authorized Shares Not Available
Outstanding Shares Not Available
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.002
Transfer Agent(s)
Pacific Stock Transfer Co.
No Response yet from dormakaba
I'll follow up with him next week (and also the TA).
m2m
Newbies, do your DD on Currah and Keevil b4 you invest here.
If you want a legitimate Canadian MJ play, check ou BLDV.
m2m
U r so smart! Wats ur IQ?
m2m
Level 2-- ETRF bidding for 26,166,666 shares at .06.
m2m
But but your honor, we had a verbal agreement.
Haha. Hope you've stocked up on Vaseline jailbird!
Oh yea this scam is worth more than my AAPL! ( don't own IGEX and never have, you and I are
connected only by SRSR)
Seriously, Currah, your days are numbered. Start counting.
Which of their other scams will ne next?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131660013
m2m
I also emailed investor relations of dormakaba and received a response from its VP. He said he "forwarded my e-mail internally, as soon as I have an answer I will get back to you".
m2m
I just contacted the TA for EDTA, Pacific Stock Transfer, and spoke to a Danielle Case (702-361-3033) She indicated that they had just recently (2/17) become the TA. She gave me the following stock info:
Issued and Outstanding 21,617,107 shares
Restricted 9,416,245
Float 12,200,862
She also gave me the general phone # she had for E-DATA, 516-484-4400 which I called. The receptionist answered the phone referring to "SANDATA".
I asked to speak to someone regarding EDTA (referencing my call to the TA). Was transferred to the company secretary (an older woman). When I gave her the reason for my call, she said she didn't thick E-Data "was around anymore". I referenced the Kaba acquisition which she claimed no knowledge of. She seemed a little nervous.
This company is located at the same address listed for EDTA on the otc markets site.
Whadayathink?
m2m
That may be true but my post is accurate since I checked with the TA on that date: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130865411
m2m
So that works out to 32,421,984 shares of dilution since 4/29/17.
m2m
From the PR:
"We will provide timely updates to shareholders on this plan in the coming days."
"coming days". Ha..that could mean anything. Would have much preferred "in the very near future" or something more specific.
m2m
You're welcome!
m2m
WRONG!!! NEWC gets paid upon delivery to port.
Email from John:
John Campo <jcampo@newcolombiaresources.com>
7:20 AM (2 minutes ago)
to me
Once we show the port receipt from the Colombian port, we get paid.
Thanks for your interest.
John
John Campo
President
New Colombia Resources, Inc. (OTCQB: NEWC)
(1)-410-236-8200 USA
(57) 318-657-0918 Colombia
jcampo@newcolombiaresources.com
Total Wine & More carries it. Check their web site for stock.
m2m